NI
U.S. National Institutes of Health (NIH), CDC and FDA

NIH/CDC/FDA SBIR & STTR Parent Grants

Funds US small businesses developing health, biomedical and diagnostic innovations toward clinical translation through NIH, CDC and FDA SBIR/STTR awards.

Between cyclesU.S. National Institutes of Health (NIH), CDC and FDAUnited States

Eligible small businesses submit SBIR or STTR applications via Grants.gov and NIH's eRA Commons ahead of one of three standard due dates that recur every year. NIH also runs a separate Commercialization Readiness Pilot programme to help existing SBIR/STTR awardees move their technology closer to market.

This umbrella covers the parent SBIR and STTR funding opportunities run across NIH, CDC and FDA for early-stage R&D in medical and health innovation, spanning diagnostics, therapeutics and public health technology. A clinical trial is optional under several of the parent calls rather than mandatory.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see where teams trip up

Guides for this application

All guides โ†’